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Abstract

Background and Specific Aims: Chronic hypoxia (CH) induced
pulmonary hypertension is mediated in part by endothelial dysfunction, involving
reduced intracellular Ca2+ levels and decreased production of endotheliumderived vasodilators and anti-mitogenic compounds. Agonist-induced endothelial
Ca2+ entry is decreased following CH due to a derangement in T-type voltagegated calcium channels (T-channels) and caveolin-1 containing membrane lipid
domains that regulate calcium influx in these cells. Considering the importance
of store-operated Ca2+ entry (SOCE) to agonist-induced Ca2+ entry, we
hypothesized that CH impairs pulmonary endothelial SOCE through altered
caveolin-1 regulation of T-channels. To test this hypothesis, we addressed the
following specific aims:
Specific Aim 1: Determine the role of T-channels in agonist-induced
calcium entry and SOCE in pulmonary arterial endothelial cells (PAEC) from
control and CH rats.
Specific Aim 2: Determine the contribution of caveolin-1 to SOCE in
PAEC from control and CH rats.
v

Experimental Approach: Fura-2 fluorescence microscopy was used to
assess either ATP-induced Ca2+ influx or SOCE resulting from depletion of
intracellular Ca2+ stores in freshly isolated PAEC from control and CH (4 wk at
0.5 atm) rats. Experiments were conducted in the presence or absence of the Tchannel inhibitor mibefradil. In separate protocols, SOCE was assessed following
pretreatment with either a peptide containing the scaffolding domain of caveolin-1
(AP-CAV) or a scrambled control peptide. Immunofluorescence microscopy was
used to evaluate the distribution of endothelial T-channels and caveolin-1, while
the density of caveolae was determined from electron micrographs of PAEC from
each group.
Results: Both ATP-induced Ca2+ influx and SOCE were attenuated in
PAEC from CH compared to control rats. Although T-channel inhibition
selectively attenuated Ca2+ responses to ATP in cells from control rats and
normalized responses between groups, mibefradil was without effect on SOCE in
control cells. Furthermore, AP-CAV augmented SOCE in cells from CH rats
while having no effect in controls. We observed similar immunofluorescent
staining for T-channels and caveolin-1 between groups, and the incidence of
endothelial caveolae was unchanged by CH.
Conclusions: CH impairs caveolin-1 regulation of SOCE in PAEC
without affecting intracellular caveolin-1 distribution or caveolar density.
However, decreased SOCE following CH appears to be independent of Ca2+
influx through T-channels.
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Introduction
Chronic hypoxia (CH) resulting from residence at high altitude or chronic
obstructive pulmonary disease leads to pulmonary hypertension (PH) through
polycythemia, vascular remodeling, and vasoconstriction. Whereas the vasoconstrictor
component of PH is mediated in part by acute effects of hypoxia to cause vascular
smooth muscle (VSM) contraction, increases in VSM contractility and endothelial
dysfunction are thought to be important contributing influences to this hypertensive
response. Such endothelial derangements are characterized not only by increased
production of endothelium-derived contractile factors, but also impaired synthesis or
enhanced bioinactivation of endothelium-derived vasodilators that collectively favor
vasoconstriction. Although mechanisms of endothelial dysfunction in PH are likely
multifaceted, reduced endothelial [Ca2+]i following CH may contribute to dysregulation
of these vasodilator pathways (Fig. 1). However, the causes of altered endothelial
calcium regulation in the hypertensive pulmonary vasculature are not well understood.
Therefore, the overall objective of this thesis is to understand mechanisms of impaired
endothelial calcium entry in this setting.
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Figure 1. Diagram depicting the hypothesis for reduced endothelial cell Ca2+ leading
to pulmonary hypertension following chronic hypoxia.
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Endothelial Dysfunction Following Chronic Hypoxia
Enhanced endothelium-dependent vasoconstriction
CH is characterized by endothelial derangement that leads to increased production
of vasoconstrictors and mitogenic compounds, including endothelin and reactive oxygen
species (ROS). Endothelin is a potent vasoconstrictor with promitogenic characteristics.
Endothelin has three isoforms endothelin-1(ET-1), endothelin-2 (ET-2), and endothelin-3
(ET-3). ET-1 is the most important in the vasculature and has been shown to be elevated
in animal models of PH (26; 27). Endothelin-1 is a 21 amino acid peptide released from
both the endothelium and smooth muscle and is a potent vasoconstrictor (22).
Endothelin-1 is released from the endothelium in response to CH (24). Under hypoxic
conditions ET-1 gene transcription is activated through a hypoxia inducible factor(HIF)
dependent mechanism (51). ET-1 acts through endothelin receptors on the membrane of
the smooth muscle and endothelium. Two isoforms of the endothelin receptor are
known, endothelin receptor A (ETA) and endothelin receptor B (ETB). Activation of the
ETA receptor on the smooth muscle leads to increased smooth muscle cell Ca2+ and Ca2+
sensitivity as well as smooth muscle cell proliferation which is the likely mechanism by
which endothelin contributes to PH (22). ETB receptors located on the endothelium lead
to increased NO production and vasodilation (52). However, in CH endothelial
dysfunction may prevent the protective effect of these endothelial receptors. Inhibition of
ETA receptors has been shown to prevent CH induced PH (7). In addition it has also been
shown that inhibition of both ETA and ETB with bosentan prevents CH induced PH (8).
These findings lead to endothelin receptor antagonists as a current therapeutic treatment
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for PH (22). These results suggest that endothelin-1 is an important mediator of CH
induced PH.
ROS are also an important component of endothelial derived vasoconstrictors.
ROS production is increased in the endothelium with CH (17) and may directly
contribute to contraction of the smooth muscle in this setting (20). ROS can also promote
vasoconstriction indirectly by impairing endothelium dependent vasodilator pathways as
(3; 25) discussed below in the third paragraph of the ‘Impairment of endothelium-derived
vasodilator pathways’.
Impairment of endothelium-derived vasodilator pathways
Production of endothelium-derived vasodilators is decreased with endothelial
dysfunction associated with CH and impaired handling of endothelial Ca2+ may
contribute. The synthesis of several endothelium-derived vasodilators is Ca2+ dependent
including NO, prostacyclin, and endothelium-derived hyperpolarizing factor (EDHF).
Endothelial nitric oxide synthase (eNOS) is the protein that produces NO. NO is
responsible for vasodilation through activation of soluble guanylyl cyclase (sGC) in the
smooth muscle and the subsequent activation of protein kinase G (PKG). eNOS is
displaced from the inhibiting protein caveolin-1 in the presence of the Ca2+-calmodulin
complex and is activated to produce NO (21). Basal production of NO has been shown to
be important in maintaining low vascular resistance in the pulmonary circulation (10).
The role of NO in CH induced PH is complex due to reports showing increased eNOS
(16; 34; 48; 60) expression levels but decreased endothelium dependent dilation and NO
production in pulmonary arteries following CH (38). Murata et al. (38) demonstrated that
eNOS phosphorylation of serine 1177, which is critical for efficient eNOS activity, is
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impaired in pulmonary endothelial cells from rats exposed to CH. These authors also
showed that eNOS interaction with the inhibitory protein caveolin-1 was increased with
CH leading to decreased production of NO. Interestingly, in this paper (38) it was also
shown that eNOS interaction with hsp90, a protein critical for proper eNOS function, is
decreased following CH. These findings suggest that eNOS production of NO is
decreased following CH.
NO bioavailability may also be impaired by increased ROS production following
CH. Jernigan et al. (19) have shown that ROS from the endothelium of isolated
pulmonary arteries from CH rats impairs exogenous NO dilation. This finding suggests
that reactive oxygen species from the endothelium suppress the effect of NO on the
smooth muscle. This could be due to ROS reacting with NO to form peroxynitrite anion
(ONOO-) (3). It has also been shown that CH increases ROS generation (39) and that
ONOO- leads to inhibition of eNOS (25). Indeed Jankov et al. (17) have shown increased
protein nitrosylation in the endothelium following CH. These findings suggest that both
proper eNOS function and endothelium dependent vasodilation are impaired in the
pulmonary circulation following CH.
Prostacyclin is a vasodilator that is formed from arachidonic acid (AA). AA is
produced by phospholipase A2 (PLA2) in a Ca2+ dependent manner. AA is converted into
prostaglandin H2 by cycloxygenase-1 (COX-1) which is converted into prostacyclin
(PGI2) by prostacyclin synthase (PGIS). PGI2 activates Gs-coupled receptors on the
smooth muscle membrane leading to vasodilation. COX inhibition has been shown to
increase pulmonary vascular tone (57). Suggesting that PGI2 contributes to tone in the
pulmonary circulation. In addition, mice over expressing PGIS show reduced arterial

5

wall hypertrophy in CH-induced-PH and some human forms of PH have shown a loss of
PGIS (13; 13; 54). These findings suggest that prostacyclin could be important in
diminished endothelium-dependent vasodilation following CH.
EDHF is a common term used to describe a number of different signaling
pathways whereby the endothelium affects the smooth muscle to cause hyperpolarization
of the muscle. One vasodilation mechanism classified as an EDHF is characterized by
the Ca2+-calmodulin complex (23; 59) activating small (SKca) and medium (IKca)
conductance Ca2+ activated potassium channels which hyperpolarize the endothelial cell
and then the hyperpolarization is conducted across to the smooth muscle cell through
myoendothelial cell gap junctions. Hyperpolarization of the smooth muscle cells leads to
a decrease in smooth muscle cell Ca2+ through inhibition of voltage gated L-typer Ca2+
channels and relaxation (9). Another EDHF pathway is called the potassium cloud
hypothesis. In this scenario the Ca2+-calmodulin complex activates efflux of potassium
through the SKca and IKca channels causing a small increase in [K+] in the space between
endothelial and smooth muscle cells. This increase in extracellular [K+] activates
vascular smooth muscle Na+/K+-ATPases and inwardly rectifying K+ channels leading to
hyperpolarization (9). A third calcium sensitive EDHF pathway involves an alternative
AA metabolite called epoxyeicosatrienoic acid (EET). EET’s are formed through
cytochrome (CYP) P450 metabolism of AA (6). The effect of EETs is to hyperpolarize
the smooth muscle through activation of large conductance potassium channels
(BKCa)(6). Morio et al. (30) showed that EDHF responses contribute to thapsigargin
induced vasodilation in normotensive rat lungs and that these pathways change in the
hypoxia induced hypertensive rat lung. They found that both gap junction dependent
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EDHF and CYP P450 dependent EDHF pathways are lost in the hypoxia induced
hypertensive lung from rats (30). Although this study illustrates that EDHF pathways are
impaired following CH, the significance of this impairment to the development of PH
remains to be established.

Dysregulation of Endothelial Cell Calcium Handling Following Chronic Hypoxia
Intracellular Ca2+ is maintained at approximately 10-7 M in endothelial cells under
resting conditions (33). Ca2+ is extruded from the cytoplasm in an ATP dependent
manner via the plasma membrane Ca2+-ATPase (PMCA) and the sarcoendoplasmic
reticulum Ca2+-ATPase (SERCA). A non ATP sensitive plasma membrane transporter,
the Na+-Ca2+ exchanger, also contributes to resting Ca2+ levels. Ca2+ enters the cell
through ion channels that temporarily open to allow Ca2+ to rapidly pass through the cell
membrane and down the electrochemical gradient for Ca2+ (33). The regulation of Ca2+
channels is also important for controlling Ca2+ in endothelial cells. One important way
Ca2+ enters the cell is when an agonist binds a receptor, leading to depletion of Ca2+ from
the endoplasmic reticulum (ER) and activation of store operated Ca2+ entry (SOCE).
Another pathway activated by an agonist binding a receptor is through the synthesis of
diacylglycerol (DAG) and is termed receptor operated Ca2+ entry (ROCE). There are
also Ca2+ channels that open in response to depolarization and allow for the influx of
Ca2+. Intracellular basal Ca2+ as well as Ca2+ entry is diminished in PAEC from CH rats
(41; 43). These pathways could lead to decreased production of vasodilators and
contribute to CH induced PH and will be discussed in the subsequent paragraphs.
Effects of CH on store- and receptor-operated calcium entry
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The mechanism of decreased basal Ca2+ in the pulmonary endothelium is
unknown but it could be dependent on decreased Ca2+ entry. Consistent with this
possibility is evidence that agonist induced Ca2+ entry is diminished in PAEC following
CH (38; 42). This response appears to be dependent on both reduced SOCE and ROCE
(44). SOCE in PAECs is diminished following CH, as measured in endothelial cells in
both intact arteries and isolated cell preparations (41). In contrast with these results,
Fantozzi et al. (11) have shown that SOCE is increased in human endothelial cells
following 72 hr hypoxic in cultured PAEC. However, these experiments were conducted
in cell culture conditions and this could explain these discrepancies. In vivo the PAEC
will be exposed to shear stress and other mechanical forces not present in cell culture. In
vivo there is also other cell to cell communication and contacts that could be very
important in the phenotype that develops in these PAEC. In addition, ROCE has also
been measured in isolated PAEC and shown to be decreased following CH (44). Thus,
impaired SOCE and ROCE following CH may account for decreased basal pulmonary
endothelial Ca2+ following CH.
There are several potential mechanisms of decreased SOCE and ROCE in PAEC
following CH. Impaired trafficking of the channels responsible for SOCE is one possible
explanation for decreased SOCE in PAEC following CH. Two canonical transient
receptor potential (TRPC) channels TRPC1 and TRPC4 have been implicated in SOCE
and other animal models of PH have shown impairment of TRPC4 trafficking to the
membrane in PAEC (36). A second potential mediator of impaired SOCE and ROCE in
PAEC following CH is protein kinase C (PKC). Interestingly, non-specific PKC
inhibition in PAEC from CH animals has been shown to restore SOCE (44). These
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results indicate that PKC has an inhibitory effect on SOCE that is mediated by CH. In
contrast PKCε appears to augment ROCE in control cells and CH inhibits this ROCE that
is in part mediated by PKCε in control cells (44). A separate protein integrated with
intracellular signaling, caveolin-1, has also been shown to be important in Ca2+ entry in
endothelial (36; 42) and caveolin-1 dysfunction could be contributing to impaired SOCE
and ROCE following however this has not been explored. A fourth potential factor in
decreased Ca2+ entry is membrane cholesterol homeostasis. Interestingly it has also been
shown that membrane cholesterol is decreased with CH and that when membrane
cholesterol is restored, Ca2+ entry is restored suggesting that decreased membrane
cholesterol could contribute to impaired SOCE and ROCE following CH (42). This
study will focus on potential mechanisms of decreased SOCE in PAEC following CH as
well as elucidating which ion channels are involved and the contribution of caveolin-1 to
this response.
Chronic hypoxia inhibits depolarization-induced calcium entry
Although endothelial cells are generally considered to be electrically unexcitable,
endothelial T-type voltage-gated calcium channels (VGCC) have been described in some
vascular beds including the brain, adrenal glands and lung (5; 56; 64). T-type VGCC are
distinct from L-type VGCC in that they activate and de-activate rapidly over a large
voltage range and they show smaller current and are activated at more hyperpolarized
membrane potentials. T-channels are categorized by their inactivation properties as α1G
(Cav3.1), α1H (Cav 3.2) and α1I (Cav 3.3) (58). Zhou et al. (64) demonstrated that Tchannel activation in pulmonary microvascular endothelial cells leads to Weibel-Palade
body exocytosis. These studies showed that activation can be through Gq linked
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receptors in response to inflammatory cytokines or through depolarization using KCl.
Furthermore, T-channels have been implicated in mediating depolarization-induced Ca2+
entry in isolated rat PAECs from control rats, as evidenced by an effect of the T-channel
inhibitor, mibefradil, to attenuate this response. Therefore, pulmonary endothelial Tchannels may play important functional roles in endothelium-dependent regulation of
vascular tone in response to stimuli that depolarize the endothelium directly or indirectly
through conducted depolarization from the vascular smooth muscle.
Similar to effects of CH to inhibit endothelial SOCE and ROCE, depolarizationinduced Ca2+ influx is lower in PAEC from CH rats compared to those of control animals
(44). Paffett et al. (43) have also shown the presence of T-channels in PAEC and that
these channels contribute to depolarization-induced Ca2+ entry and ATP-induced ROCE.
Following CH, this mibefradil sensitive component of ROCE is lost suggesting that
reduced ROCE in CH is in part mediated through dysregulation of T-channels. . PKCε
was shown to be required for T-channel function in ROCE in the control cells but CH
impaired PKCε activation of T-channels (43). This study implies that CH causes a loss
of a PKC activated Ca2+ influx pathway that is dependent on mibefradil-sensitive
channels. T-channels are important mediators of ROCE and depolarization induced Ca2+
entry in PAEC from control rats and their function is lost with CH which could be a
contributing factor in the CH induced decrease in basal Ca2+ in PAEC.

Role of Endothelial Caveolin-1 in Calcium Homeostasis and Pulmonary
Hypertension
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Caveolae are small invaginations in the plasma membrane first described by
Yamada (61). Caveolae are most notably present in epithelial cells, endothelial cells,
adipocytes and fibroblasts in the lung (4; 14; 50). Identification of the proteins that make
up caveolae and the generation of knock-out mice for those genes has implicated
caveolae in a large number of different physiological processes (15). Caveolin-1 is the
most abundant protein in caveolae and is critical for caveolae formation (12). It is a
membrane associated protein that is found in lipid dense regions of the plasma
membrane. The scaffolding domain of caveolin-1 interacts with many different proteins
(28) including Ca2+ conducting ion channels (36; 45). It has been shown that caveolin-1
is important in Ca2+ entry (42) trafficking of calcium channels and important in agonist
induced Ca2+ entry (36).
Pulmonary hypertension is associated with caveolin-1 dysfunction and
understanding the role of caveolin-1 in this pathology is important. Caveolin-1 knockout
mice develop pulmonary hypertension as well as right ventricular hypertrophy and
diminished agonist induced Ca2+ entry in PAEC (62). Monocrotaline treated rats develop
pulmonary hypertension accompanied with a loss in caveolin-1 expression in the lung
(18). Interestingly it has been shown that administering a cell permeable version of the
scaffolding domain of caveolin-1 to monocrotaline treated rats alleviates the pulmonary
hypertension and restores the expression of caveolin-1 (18). Several investigators have
examined the mechanism of the resultant pulmonary hypertension following caveolin-1
dysfunction. Murata et al. (36) generated a mouse line that only expressed caveolin-1 in
the endothelium by breeding a caveolin-1 global knock out mouse with a mouse overexpressing caveolin-1 in the endothelium resulting in a mouse that only expressed
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caveolin-1 in the endothelium. These mice with rescued caveolin-1 expression showed
normal pulmonary pressures with the full knock-out displaying pulmonary hypertension
(35). These investigators went on to show that Ca2+ entry in the pulmonary endothelium
of the knock out mouse was diminished in comparison to the pulmonary endothelial cells
expressing caveolin-1 (37). Using silencing RNA these investigators were able to
determine that calcium entry was diminished due to dysfunctional TRPC1 and TRPC4
cation channels in the endothelium. Using immunofluorescence it was shown that
TRPC4 trafficking was dysfunctional in the cells not expressing caveolin-1 (36). This
study shows that caveolin-1 is important for ion channel trafficking and Ca2+ entry in the
pulmonary endothelium and that these functions are lost in pulmonary hypertension.
Caveolin-1 has also been shown to be important in the inhibition of eNOS
activity (21). This has led other investigators to study the role of caveolin-1 in regulating
eNOS in pulmonary hypertension. Caveolin-1 is primarily thought to be important in
trafficking the eNOS protein to the membrane and bringing it in close proximity to
essential proteins needed for the formation of nitric oxide as well as inhibiting eNOS
activity until there is sufficient Ca2+ levels in the cell at which point the calmodulin-Ca2+
complex displaces the caveolin-1 protein from eNOS allowing for the formation of NO
(29). Mukhopadyay et al. (31) demonstrated that eNOS trafficking is impaired in
pulmonary vascular endothelial cells that are treated with monocrotaline or hypoxia.
Their study illustrated that eNOS is trapped in the golgi following monocrotaline or
hypoxic treatment and they hypothesized that the NO produced by the golgi trapped
eNOS cannot reach the vascular smooth muscle to illicit vasorelaxation (32). Other
investigators (63) have shown that if eNOS is genetically deleted along with caveolin-1
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then pulmonary hypertension doesn’t develop like it normally would in a caveolin-1
knock out mouse. These investigators show that the absence of caveolin-1 causes an
increase in NO production leading to PKG nitrosylation and cellular dysfunction (63).
These studies demonstrate that persistent eNOS activation, leading to detrimental protein
nitrosylation, secondary to decreased expression of caveolin-1 is a contributing factor to
PH. This illustrates the importance of caveolin-1 regulation of eNOS and how the
derangement of this interaction contributes to pulmonary hypertension.
More recent studies suggest that caveolin-1 dysfunction contributes to decreased
Ca2+ entry in PAEC from CH rats (42). In this paper the authors found that acute
application of the caveolin-1 scaffolding domain restores the lost ATP-induced Ca2+
entry in PAEC from CH rats. Interestingly this study also found that decreased
membrane cholesterol inhibits agonist induced Ca2+ entry in PAEC from control rats but
has no effect on agonist induced Ca2+ entry in PAEC from CH rats. We also show that
there is reduced membrane cholesterol in the PAEC from CH rats. These results indicate
that there is both caveolin-1 dysfunction and alteration in cholesterol homeostasis
contributing to reduced agonist induced Ca2+ entry in PAEC following CH. One possible
explanation is the caveolin-1 dysfunction with CH also leads to impaired trafficking of
cholesterol to the membrane by caveolin-1 (55). However, whether reduced membrane
cholesterol mediates caveolin-1 dysfunction in this setting is a topic of future
investigation.
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Rationale and Specific Aims
From the above discussion, it appears that CH inhibits ROCE mediated by Tchannels and that agonist induced Ca2+ entry is diminished in CH due to caveolin-1
dysfunction. However whether decreased SOCE following CH is caused by impaired
caveolin-1 regulation of ion channels and the contribution of T-channels to this response
is currently unknown. Therefore, we tested the hypothesis that CH decreases pulmonary
endothelial SOCE through altered caveolin-1 regulation of T-channels (Fig. 2).

Specific Aim 1: Determine the role of T-channels in agonist-induced calcium
entry and SOCE in PAEC from control and CH rats.
Hypothesis: T-channel dysfunction inhibits pulmonary endothelial SOCE and
agonist-dependent calcium entry following CH.
Rationale: Previous studies from our laboratory (41) have demonstrated decreased
SOCE in PAEC from CH rats. This information in combination with evidence that CH
impairs T-channel mediated Ca2+ influx in the pulmonary vascular endothelium led us to
examine the role of T-channels in SOCE. In this scenario T-channel activation would be
secondary to SOCE and would require the influx of Na+ and Ca2+ leading to the
depolarization of the endothelial cell membrane and the opening of T-channels (depicted
in Figure 2). T-channel function with CH could be impaired by altered membrane
localization or interference with acute translocation of
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the channels to the membrane following agonist stimulation. Therefore, we wanted to
determine if these channels are also important in agonist induced Ca2+ entry and SOCE
and if they are dysfunctional following CH.
Approach: Fura-2 fluorescence microscopy was used to assess either ATPinduced Ca2+ influx or SOCE in freshly isolated PAEC from control and CH (4 wk at 0.5
atm) rats. The contribution of T-channels to these responses was assessed using the Tchannel inhibitor mibefradil. In addition, immunofluorescence confocal microscopy was
used to evaluate the cellular distribution of endothelial T-channels under basal conditions
and following administration of ATP in cells from each group.

Specific Aim 2: Determine the contribution of caveolin-1 to SOCE in PAEC from
control and CH rats.
Hypothesis: CH impairs caveolin-1 regulation of ion channels necessary for
pulmonary endothelial SOCE.
Rationale: Previous studies from our laboratory (42) have shown that
administration of the scaffolding domain of caveolin-1 restores diminished agonist
induced Ca2+ entry that is normally observed in PAEC from CH rats suggesting that CH
induced caveolin-1 dysfunction impairs agonist induced Ca2+ entry. However, whether
caveolin-1 dysfunction contributes to impaired SOCE to mediate this response is
unknown. Therefore we set out to address the question of whether the caveolin-1
scaffolding domain can restore SOCE in endothelia from CH rats independent of receptor
stimulation. We also explored how CH is modulating caveolin-1 function, if it is through
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trapping of caveolin-1 in microsomal compartments leading to decreased caveolae
density.
Approach: SOCE was assessed in isolated PAEC from each group following
pretreatment with either a peptide containing the scaffolding domain of caveolin-1 (APCAV) or a scrambled control peptide. Immunofluorescent staining of caveolin-1 was
assessed by confocal microscopy, and the incidence of caveolae was determined from
electron micrographs of PAEC from each group.
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Methods
All protocols used in this study were approved by the Institutional Animal Care
and Use Committee of the University of New Mexico.
Experimental groups
Male Sprague-Dawley rats between 200-250 grams were obtained from Harlan
Industries. Rats exposed to CH were placed in a hypobaric chamber (~380 torr) for 4
weeks. Age-matched controls were kept in cages at ambient conditions (~630 torr). The
hypobaric chamber was open 3 times/week to provide rat chow, clean water, and new
bedding. Animals were maintained on 12:12 hr light:dark cycle.
Isolation of pulmonary arterial endothelial cells
Rats were euthanized with sodium pentobarbital (32.5 mg i.p.) following a
midline thoracotomy the heart and lungs were exposed. The left lung was excised and
placed in ice cold HEPES buffered salt solution (HBSS) containing (in mM) 150 NaCl, 6
KCl, 1MgCl, 1.8CaCl2, 10 HEPES, and 10 glucose, titrated to pH 7.4 with NaOH
(Sigma). The lung was pinned down in a Silastic coated dissection dish containing ice
cold HBSS. Arteries (200-400 μm inner diameter) from the cranial section of the left
lung were cleared of lung tissue and cut longitudinally. Arteries were placed in HBSS
containing 0.2 mg/ml of dithiothreitol and 0.2 mg/ml papain at 37°C for 45 minutes.
Vessels were removed and placed in 1 ml of HBSS containing 2 mg/ml BSA and placed
on ice for 10 minutes. Endothelial cell sheets were released by gentle trituration with a
small bore fire-polished Pasteur pipette and placed back on ice. Two hundred fifty ml of
the cell suspension was placed on poly-L-lysine coated coverslips for 30 minutes
following mounting on an inverted fluorescence microscope (Nikon Eclipse, TS100).
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Assessment of Agonist-Induced and Store-Operated Ca2+entry
Isolated endothelial cells were incubated with fura-2-AM (3µM and 0.05%
pluronic acid; Invitrogen), a ratiometric fluorescent Ca2+ indicator, for 5 minutes at room
temperature and then washed with HBSS for 15 minutes at 37ºC. Ratiometric changes in
endothelial cell [Ca2+]i were determined by alternating a xenon arc lamp light source
between 340 and 380 nm bandpass filters at 1 Hz (Ionoptix Hyperswitch) and the
resultant fura-2 fluorescent emissions (F340/F380) were detected at 510 nm with a
photomultiplier tube. To assess ATP induced Ca2+ entry, the cells were superfused with
Ca2+ free HBSS containing the same contents as HBSS but CaCl2 was substituted for
equimolar MgCl2. Following stabilization of the fura-2 emission ratio ATP (20 µM) was
added to deplete intracellular Ca2+ stores. Following stabilization of the ratio, Ca2+
containing HBSS with ATP was added back to the superfusate and a sustained increase in
fura-2 emission ratio was observed. This increased fura-2 emission ratio represents both
SOCE and ROCE components of agonist-induced Ca2+ influx (figure 3). To determine
the magnitude of Ca2+ response the area under the curve (AUC) was calculated and
recorded in arbitrary units for exactly 4 minutes immediately following the initial
increase in Ca2+ (NCSS.LLC, 2007). To determine the role of T-channels in this
response we used the T-channel inhibitor mibefradil (10 µM; Sigma) which is the
concentration previously reported in Paffett et al. (44) to inhibit depolarization induced
Ca2+ entry independent of L-channels and T-channel currents in neonatal
cardiomyocytes. Mibefradil was added to the HBSS following fura 2-AM loading and
maintained throughout the experiment.
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In separate experiments examining SOCE, the endoplasmic reticulum Ca2+
ATPase inhibitor, cyclopiazonic acid (CPA; 10 µM; Calbiochem) was added during the
Ca2+ free superfusion period. Ca2+ mobilization was observed and following stabilization
of the F340/F380, Ca2+ and CPA containing HBSS was added back and the F340/F380
increased and plateaued. SOCE was assessed as the change in F340/F380 after repletion of
extracellular Ca2+. To determine the role of caveolin-1 in SOCE following CH we used a
peptide containing the scaffolding domain of caveolin-1 attached to a cell permeable
peptide antennapedia (AP). Endothelial cells were incubated with 10 µM of the
caveolin-1 scaffolding domain peptide (AP-cav) for 30 minutes before fura 2-AM
loading. In control experiments, a scrambled peptide conjugated to the AP sequence
(AP-scram) was used to rule out potential non-specific effects of peptide incubation. For
experiments examining the role of T-channels in SOCE, mibefradil (10 µM) was added
to all solutions following the incubation with fura 2-AM.
Immunofluorescence Microscopy for Caveolin-1 and T-type Calcium Channels
Endothelial cells dissociated from small pulmonary arteries were allowed to
adhere to 35 mm cover slips for 1 hour prior to fixation with 4% paraformaldehyde for 10
minutes. Cells were then permeabilized with 0.01% Triton-X for 10 minutes and then
placed in 3% donkey serum for 1 hr. at room temperature. Following blocking and
fixation, the cells were incubated overnight at 4˚C with rabbit polyclonal caveolin-1
antibody (1:100, Santa Cruz, Santa Cruz CA, USA). Dylight 649 donkey anti-rabbit
secondary antibody (Jackson Immunoresearch Laboratories, Westgrove, PA, USA) was
used to detect the primary antibody. Nuclei were labeled with Sytox (1:10,000) and
samples were visualized with a confocal laser scanning microscope (LSM 510; Carl Zeiss
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Figure 3. A) Experimental protocol depicting ATP-induced Ca2+ entry. ATP-induced Ca2+ entry
was defined by measuring the AUC for the increase in F340/F380 following substitution of Ca2+
containing HBSS for Ca2+-free HBSS. The base line was set at the point where F340/F380 was
stabilized in Ca2+-free HBSS containing ATP. B) SOCE was defined by the change in F340/F380
from Ca2+-free HBSS with CPA to Ca2+ containing HBSS in the presence of CPA.
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Inc. Thornwood, NY, USA) with a 63X oil immersion lens. Nonspecific binding of the
secondary was determined by omitting primary antibody.
To determine if CH alters basal or agonist-stimulated T-channel distribution,
similar methods were used to label T-channels in control and CH PAEC before and after
agonist stimulation, However, prior to fixation, the cells were incubated with either ATP
(20 µM) or vehicle for 60 seconds at room temperature. Rabbit monoclonal antibody
(1:100, Alomone Labs, Ltd., Jerusalem, Israel) for Cav3.1 were used for the overnight
incubation (4ºC). The same secondary antibody used for caveolin staining was used and
nonspecific binding of the secondary antibody was determined by omitting primary
antibody. Five to 15 sheets from three separate rats in each group were observed.
Transmission Electron Microscopy to Assess Caveolar Density
The heart and lungs were exposed by midline thoracotomy in sodium
pentobarbital (200 mg kg-1 i.p.) anesthetized rats. Heparin (100U) was injected into the
right ventricle and the pulmonary artery cannulated with a 13-gauge needle stub. The
lungs were perfused at a pressure of 15 cmH2O with 100 ml of physiological saline
solution (PSS) containing (in mM) 129.8 NaCl, 5.4 KCl,0.83 MgSO4, 19 NaHCO3, 1.8
CaCl2, and 5.5 glucose, with 4% (wt/vol) albumin, 10-4 M papaverine, and 1000 U of
heparin. The lungs were then perfused at the same pressure with 100 ml of fixative
(phosphate buffered saline containing 4% paraformaldehyde, 0.1% glutaraldehyde, and
10-4 M papaverine). Samples of lung tissue were then fixed for transmission electron
microscopy with 3% formaldehyde, 2% glutaraldehyde in 0.1M sodium cacodylate
buffer, post-fixed in reduced osmium tetroxide (1% OsO4 and 0.5% potassium
ferrocyanide), en bloc, stained with 1% uranyl acetate, dehydrated and embedded in
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epoxy resin. Caveolae between 60-100 nm diameter were counted at the membrane of
endothelial cells in arterial sections and divided by the membrane length in µm using
NIH Image J software. Vessels from 3 rats/group were analyzed. A total of 70 images
encompassing 21 cells and 667 m of membrane were analyzed from arteries of control
rats, whereas 84 images encompassing 25 cells and 758 m of membrane were analyzed
in the CH group.
Calculation and statistics
Data are expressed as means ± S.E. Values of n refer to the number of rats. A
one-way or two-way analysis of variance was used where appropriate for comparison
between groups. Individual groups were compared using the Student-Newman-Keuls test
and a probability of ≤0.05 was accepted as statistically significant.
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Results
Specific Aim 1: Determine the role of T-channels in agonist-induced calcium entry and
SOCE in PAEC from control and CH rats.
Hypothesis: T-channel dysfunction inhibits pulmonary endothelial SOCE and agonistdependent calcium entry following CH.
Effect of mibefradil on ATP-induced Ca2+ entry
ATP induced Ca2+ entry was reduced in endothelial cells from CH rats compared to
control rats as previously reported (42). The T-channel inhibitor mibefradil lowered
ATP-induced calcium influx in controls cells without altering the response in cells from
CH rats, resulting in similar Ca2+ entry between groups (Figure 4). We also saw similar
results in endothelial cells from larger vessels (Appendix Figure 1) indicating that this
response is not dependent on vessel size.
T-channel immunofluorescence in PAEC
To determine if diminished T-channel mediated Ca2+ entry following CH is
associated with altered T-channel intracellular localization of these channels, T-channels
were immunofluorescently labeled in isolated PAEC from control and CH rats. It is also
possible that ATP induces a change in the localization of T-channels that confers Ca2+
entry that is not present in the PAEC from CH rats. However, T-channel
immunofluorescence appeared similar between groups and between basal and ATPstimulated conditions (Figure 5).
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Figure 4. T-channel dependent Ca2+ entry is lost in PAEC from CH rats. The Tchannel inhibitor mibefradil (10 µM) diminished ATP-induced (20 µM) Ca2+ entry in
PAEC from control rats but is without effect in PAEC from CH rats (n=5-9 rats per
group). *P ≤ 0.05 vs. control vehicle. Data are mean S.E.
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Figure 5. T-channel labeling in PAEC appears unaltered by ATP (20 µM) or CH. PAEC
labeled for T-channels (green) from control and CH animals. In the right panels cells were
fixed 60 seconds after ATP (10 μM) or vehicle administration. Scale bar (red) equals 50 μm.
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Role of T-channels in SOCE
Attenuated ATP-induced Ca2+ responses following CH appear to involve loss of Tchannel dependent Ca2+ influx (Figure 4), however, whether this effect of CH reflects a
reduced role for T-channels in the SOCE component of agonist-induced Ca2+
mobilization is not clear. To examine this possibility, we initially set out to evaluate a
potential contribution of T-channels to SOCE in PAEC from control rats. However, we
found that mibefradil was without effect on SOCE in these cells (Figure 6), thus arguing
against a role for T-channel in SOCE following CH.

Specific Aim 2: Determine the contribution of caveolin-1 to SOCE in PAEC from
control and CH rats.
Hypothesis: CH impairs caveolin-1 regulation of ion channels necessary for pulmonary
endothelial SOCE.
Caveolin-1 scaffolding peptide augments SOCE following CH
SOCE was diminished in the CH group as described previously (41). Although
administration of the caveolin-1 scaffolding domain (AP-Cav) was without effect on
SOCE in control cells, AP-cav augmented SOCE in cells from CH rats compared to those
treated with the scrambled control peptide. This effect of AP-cav in CH cells resulted in
greater SOCE compared to similarly treated control cells (Figure 7). This effect was also
observed in endothelial cells from the main pulmonary artery (Appendix Figure 2).
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Figure 6. T-channels do not contribute to SOCE in PAEC from control rats. SOCE
is defined as the measured change in F340/F380 (ΔR) fluorescence upon repletion of
extracellular Ca2+ (1.8 mM) in the presence or absence of mibefradil (n=5 per
group). Data are mean S.E.
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Figure 7. Administration of the scaffolding domain of caveolin-1, AP-cav (10 µM) enhances
SOCE in PAEC from CH rats. AP-cav is without effect in control PAEC. * = P≤ 0.05 vs.
AP-scram control. # = P≤ 0.05 vs. AP-cav control. ** = P≤ 0.05 vs AP-scram CH. (n=5-7
per group). Data are mean S.E.
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Caveolin-1 immunofluorescence and caveolar density
Cells freshly isolated from control and CH rats demonstrated similar
immunofluorescent staining for caveolin-1 (Figure 8). No staining was observed in
sections treated only with secondary antibody. In addition, quantification of caveolar
density from transmission electron micrographs revealed no difference between groups
(Figure 9 and 10).
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Figure 8. Immunofluorescence images of caveolin-1 (red) in freshly dispersed pulmonary
arterial endothelial sheets from control (left) and chronically hypoxic (CH; right) rats.
Nuclei are labeled green.
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Figure 9. Transmission electron microscopy was used to determine the number of caveolae in the
endothelium of pulmonary arteries from control and CH rats. Representative electron micrographs
at low and high magnification of caveolae (denoted by arrows) in arteries from control (left) and CH
(right) rats. N, nucleus; EL, elastic lamina.
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Figure 10. Caveolar density is expressed as the number of caveolae per µm length of
membrane (n = 3 rats/group). There were no significant differences.
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Discussion
The overall objective of this thesis was to examine the potentially altered role of
T-channel and caveolin-1 function in attenuated pulmonary endothelial SOCE following
CH. The major findings of this project are: 1) ATP-mediated PAEC Ca2+ entry was
attenuated following CH; 2) mibefradil inhibited this response to ATP in PAEC from
control but not CH rats, thus supporting a role for T-channel dysfunction in reduced
agonist-dependent Ca2+ influx following CH; 3) in contrast, SOCE was unaltered by
mibefradil in PAEC from control rats; 4) the scaffolding domain of caveolin-1 restored
SOCE in PAEC from CH rats, while having no effect in control cells; 5) however, CH
did not alter the intracellular distribution of caveolin-1 or incidence of caveolae in PAEC.
We conclude that reduced SOCE in endothelial cells from pulmonary hypertensive
arteries is unrelated to T-channel dysfunction, but rather involves an effect of CH to
impair caveolin-1 dependent regulation of other ion channels required for SOCE.
Previous studies from our laboratory have shown that SOCE, ROCE and
depolarization induced Ca2+ entry are attenuated in PAEC following CH (41; 43).
Consistent with these previous findings we presently observed that ATP-induced Ca2+
entry is diminished in PAEC from CH rats, which likely involves both SOCE and ROCE
components. Although the mechanism by which CH attenuates agonist induced Ca2+
entry and the specific ion channels involved are not fully understood, a recent study from
our group found that the ROCE component of this response is impaired following CH
due to a reduced contribution of T-channel mediated Ca2+ influx (43). Consistent with
these observations, ATP mediated Ca2+ entry was diminished in the presence of
mibefradil, a T-channel inhibitor, in PAEC from control rats but not in PAEC from CH
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rats. This infers that T-channel dysfunction contributes to the diminished ATP-induced
Ca2+ entry in PAEC from CH rats. Potential mechanisms by which T-channel
dysfunction is impaired following CH include diminished T-channel expression or
reduced cell membrane expression. However, our qualitative assessment of T-channel
immunofluorescence did not reveal apparent differences in staining between groups, nor
did we observe any differences in localization following ATP stimulation in cells from
control and CH groups. These finding suggest that other modes of regulation are
involved in T-channel dysfunction following CH.
T-channel mediated Ca2+ influx in the endothelium could be important in the
development of PH. It is possible that vascular smooth muscle cell depolarization caused
by acute hypoxia or other stimuli could be conducted by myoendothelial gap junctions to
the endothelium, leads to an increase in intracellular Ca2+ and production of vasodilators
and antimitogenic factors. This could serve to buffer the constrictive response to acute
hypoxia. However, CH leads to a loss of proper T-channel function and this could
exacerbate the development of PH in CH.
It is unknown if T-channels play a role in the diminished SOCE component of this
response. It is possible that T-channels contribute to SOCE secondary to membrane
depolarization following cation influx through non-selective cation channels activated
during the SOCE response; although such a role for voltage gated Ca2+ channels has not
been previously described. However, we did not observe an effect of mibefradil on
SOCE in PAEC from control cells indicating that T-channels do not contribute to SOCE
in control conditions. These results suggest that CH alters other ion channels involved in
the SOCE response, most likely members of the TRPC family including TRPC1 and
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TRPC4 that have previously been implicated in mediating SOCE in endothelial cells (47;
53).
Recent studies from our laboratory suggest that attenuated agonist-induced
pulmonary endothelial Ca2+ entry following CH results from a derangement of caveolin-1
containing cholesterol-enriched membrane domains (42). For example, we found that
ATP-induced Ca2+ entry and inward cation currents are diminished in PAEC from CH
rats and that this Ca2+ entry can be restored with the administration of a cell permeable
caveolin-1 scaffolding domain peptide. However, this earlier study did not address the
role of caveolin-1 in diminished SOCE following CH, which is why we decided to look
at the potential role of caveolin-1 in SOCE. We presently found that caveolin-1
dysfunction in PAEC from CH rats may lead to diminished SOCE. These studies suggest
that CH decreases agonist-induced Ca2+ in part by impairing caveolin-1 dependent
regulation of the ion channels required for SOCE. However, whether caveolin-1
dysfunction similarly accounts for diminished ROCE and depolarization induced Ca2+
entry following CH remains to be determined.
There are several potential mechanisms that may account for diminished
caveolin-1 regulated SOCE in PAEC from CH rats. For example, it is possible that CH
decreases caveolin-1 expression and/or impairs caveolin-1 dependent trafficking of ion
channels to the membrane. Indeed, Jasmin et al. (18) showed that caveolin-1 expression
is down regulated in monocrotaline treated rats that develop pulmonary hypertension.
Furthermore, Murata et al. (36) observed impaired trafficking of ion channels to the
membrane in PAEC from caveolin-1 knock out animals. Although we did not observe
apparent alterations in either PAEC membrane localization or expression of cav-1 after
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CH exposure, these findings do not exclude the possibility that attenuated SOCE in
PAEC from CH rats results from impaired trafficking of ion channels to the cell
membrane.
It is also possible that caveolin-1 dysfunction following CH leads to altered
membrane micro-domains that bring critical SOCE components within close proximity to
each other. Another possibility is that caveolin-1 dysfunction leads to a decrease in the
number of caveolae leading to an un-organized distribution of the critical proteins needed
for SOCE such as STIM-1 and TRPC1 (46) and impaired SOCE function. Indeed,
caveolin-1 deficient mice lack caveolae (62) and monocrotaline treated rats displaying
pulmonary hypertension show a reduction in the number of caveolae in the endothelium
(49). However, we did not see a difference in caveolar density between the PAEC from
the control and CH groups. Alternatively, our recent paper shows that this effect of CH
may be attributed to altered membrane cholesterol content (42). In this paper it was
observed that PAEC from CH rats have diminished membrane cholesterol. Consistent
with CH causing a decrease in membrane cholesterol Nguyen et al. (40) have shown that
hypoxia limits cholesterol synthesis in a hypoxia inducible factor dependent manner.
Paffett et al. (42) also showed that agonist induced Ca2+ entry is diminished when
cholesterol is depleted from PAEC from control rats and that restoring membrane
cholesterol in PAEC from CH rats restores agonist induced Ca2+ entry. Reduced
membrane cholesterol could therefore be a contributing factor to the decreased SOCE we
see in PAEC from CH rats.
Limitations of this study include problems associated with isolating PAEC from
rats because by doing this we removed the effects of shear stress as well as other
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mechanical forces. Shear stress is an important physiological stimulus for Ca2+ entry in
endothelial cells (1) and could be an important mediator of eNOS activity possibly
through regulation of basal Ca2+. Indeed if shear-induced Ca2+ entry is attenuated
following CH, this could lead to further decreases in basal Ca2+ and impaired synthesis of
vasodilator and antimitogenic factors. An additional limitation is the use of
pharmacological agents to induce SOCE. Inhibition of proper ER function and
submitting cells to a Ca2+ free extracellular solution does not take place in vivo.
Additionally, dissociating the endothelial cells from the vessel could alter function.
However, previous studies from our laboratory have demonstrated both reduced
endothelial basal Ca2+ and reduced SOCE in intact isolated arteries from CH rats.
Previous studies from our laboratory have also documented that vascular smooth muscle
cells are depolarized following CH and this depolarization could be conducted to the
endothelial layer. The isolation of these cells leads to a loss of the cell to cell connections
that these cells have in vivo. It is also important to note that there is changing pressure
and radial stretch with normal respiration in the lung which also exerts mechanical forces
on the vascular endothelium which could also influence Ca2+ entry. Another limitation
was our interpretation of immunofluorescence data because we were unable to quantify
fluorescent intensity in these images. Future studies are needed to determine gene and
protein levels and one possible technique for doing this could be labeling endothelial
cells and sorting them using flow cytometry which would allow us to have a pure
endothelial isolate with which we could conduct quantitative PCR or western blotting.
Another limitation is the use fura-2 to measure a change in global intracellular Ca2+
which does not detect the effect that local changes of Ca2+ might have. These localised
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changes could have profound effects if they are localized in the same region as eNOS for
instance because there might be much larger differences in Ca2+ levels between PAEC
from control and CH animals in eNOS localized regions that we are not detecting. This
could greatly affect the production of vasodilators and lead to a severe decrease in
vasodilation and antimitogenic factor production in CH. We could address this issue in
future studies by using a faster Ca2+ indicator like fluo-4 and using a spinning disc
confocal microscope to detect these changes. Another potential limitation is the lack of
specificity of mibefradil for inhibition of T-channels. However Paffet et al. (44) have
shown that the concentration employed in this study inhibits T-channel currents in
neonatal cardiomyocytes and inhibits depolarization induced Ca2+ influx in PAEC
independent of L-channel inhibition. Our animal model of CH induced PH is limited in
its dissimilarities with human forms of pulmonary hypertension. However, this model is
pretty good and in fact may treatments for PH have been developed from studies using
this model.
Preventing the deleterious effects of endothelial dysfunction is a hallmark in the
treatment of PH. Numerous treatments exist to try and offset the effect of endothelial
dysfunction including administration of NO, prostacyclin analogs, endothelin receptor
antagonist and phosphodiesterase inhibitors (2) and this study as well as others suggest
that the scaffolding domain of caveolin-1 could be a potential treatment for endothelial
dysfunction. One side effect of the therapeutic application of AP-cav is that its effect is
not limited to the pulmonary circulation. Interestingly recent studies from our lab have
shown that the scaffolding domain of caveolin-1 restores systemic vasoreactivity
following CH (unpublished results). The results in this project and our recent paper (42)
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suggest that application of the caveolin-1 scaffolding domain could reduce the deleterious
effect of decreased Ca2+ entry in PAEC in pulmonary hypertensive patients.
In conclusion, our present findings show decreased agonist induced Ca2+ entry and
decreased SOCE which is mediated by dysfunctional caveloin-1. Future studies should
determine if caveolin-1 levels are similar between groups. The identity of the channels
normally involved in SOCE is still unknown which should be a critical goal for future
studies. Another important future direction would be determining how caveolin-1
interacts with these channels and what the mechanism of caveolin dysfunction is in CH.
There also is a need for future studies to address the role of altered cholesterol synthesis
leading to decreased agonist induced Ca2+ entry following CH in PAEC. Future studies
might determine whether chronic administration of AP-cav can alleviate the symptoms of
CH induced PH and whether or not this can restore basal Ca2+ and Ca2+ entry in
endothelial cells. It would also be interesting to study the effects of cholesterol
repletion/depletion in vivo perhaps through the use of statins to inhibit cholesterol
synthesis. The results of this study suggest caveolin-1 dysfunction is an important area of
study in order to understand the physiological mechanisms contributing to pulmonary
hypertension.
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Appendix
The protocols are the same for these studies as the ones listed in the methods
section. The only difference is the mean size of the vessels. For the ATP induced Ca2+
entry experiments the largest intrapulmonary artery running longitudinally down the side
of the left lung was dissected and endothelial cells were isolated. For the SOCE
experiments the main pulmonary artery was dissected and utilized for endothelial cell
isolation.
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Appendix figure 1. ATP-induced Ca2+ entry is diminished in large intrapulmonary
artery endothelial cells (LIPAEC) from CH rats in comparison to controls. The Tchannel inhibitor mibefradil (10 µM) inhibited Ca2+ entry in LIPAEC from CH rats
but not controls implying that T-channel function is lost in LIPAEC from CH rats
(n=5-8 rats per group). *P ≤ 0.05 vs. control. Data are mean S.E.
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Appendix Figure 2. Caveolin-1 dysfunction contributes to diminished SOCE in main
PAEC (MPAEC) from CH rats. The scaffolding domain of caveolin-1 restores and
enhances SOCE in MPAEC from CH rats but has no effect in controls (n=5-7 rats per
group). * P≤ 0.05 vs. AP-scram control, # P≤ 0.05 vs. AP-cav control, ** P≤ 0.05 vs. APscram CH. Data are mean S.E.
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